Researchers at UVA Health have found that a class of HIV drugs called nucleotide reverse transcriptase inhibitors (NRTIs) may significantly reduce the risk of developing Alzheimer’s disease. Their ...
UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's disease after discovering that patients taking the drugs are substantially ...
The researchers note that patients taking other types of HIV medications did not show the same reduction in Alzheimer's risk as those on NRTIs. Based on that, they say that NRTIs warrant clinical ...
Four men in King County have been diagnosed with a strain of HIV that is extremely hard to treat, and health officials are concerned it could spread further. At least two types of HIV drugs don’t work ...
Human immunodeficiency virus (HIV) infections are lifelong, potentially life-threatening infections that weaken an individual’s immune system, rendering them susceptible to severe secondary infections ...
Four men in King County have been diagnosed with a strain of HIV that is extremely hard to treat, and health officials are concerned it could spread further. At least two types of HIV drugs don’t work ...
Share on Pinterest New research suggests that HIV drugs may have a protective effect against Alzheimer’s. Willie B. Thomas/Getty Images Researchers at UVA Health have found that a class of HIV drugs ...
“It’s estimated that over 10 million people around the world develop Alzheimer’s disease annually,” said UVA Health researcher Jayakrishna Ambati, MD. “Our results suggest that taking these drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback